Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 460

Pharmascience treats Aegera

Pharmascience, a Canada-based generic pharmaceutical company, has acquired corporate venturing-backed local peer Aegera Therapeutics for an undisclosed amount.

Jun 1, 2011

Solazyme slips past pricing range

The company issued nearly 11 million shares at $18 each compared to an expected upper range of $17 per share prior to its initial public offering. A further 1.65 million shares can be sold if demand remains strong as it began trading at $20 each.

May 27, 2011

MerchantCircle finds its Reply

The combined business, called Reply, estimated revenues of more than $100m next year.

May 27, 2011

Tesco hears the word on BzzAgent

IDG Ventures Boston, the corporate venturing unit of US-based publisher International Data Group before it became independent and renamed Flybridge, and venture capital firm General Catalyst Partners invested $13.75m in BzzAgent in 2006.

May 27, 2011

SanDisk stores Pliant Technology

Pliant Technology becomes SanDisk's Enterprise Storage Solutions business.

May 27, 2011

ESPN jogs to Active Network listing

Active Network offered 8.2 million shares in its flotation, and selling stockholders sold 2.8 million.

May 27, 2011

GE snaps up FMC-Tech

GE invested $55m in 12 companies in November from its $200m Ecomagination competition, including FMC-Tech.

May 27, 2011

Yandex prices for IPO success

Yandex sold more than 52 million ordinary shares at $25 each compared to a planned $22 to $24 range, for an initial market cap of about $8bn before a 55% first day pop in its share price.

May 27, 2011

SMSC crosses over to BridgeCo

In 2004, chip makers Intel and Infineon's corporate venturing fund participated in BridgeCo's $16m series C financing round, with Intel Capital having previously invested in its B round.

May 27, 2011

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here